Lung Inflammation as a Therapeutic Target in Cystic Fibrosis
- 1 October 2004
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 31 (4), 377-381
- https://doi.org/10.1165/rcmb.2004-0124tr
Abstract
Cystic fibrosis (CF) lung disease is characterized by chronic neutrophilic inflammation and infection. Effective management of airway inflammation could complement other therapies for the treatment of CF. Recent progress has been made in understanding the signaling pathways regulating inflammatory cytokines in the lung. Here we examine the mechanisms responsible for inflammation in the CF lung, and discuss potential therapeutic strategies targeting inflammation.Keywords
This publication has 60 references indexed in Scilit:
- Immune Responses to Recombinant Adeno-Associated Virus Vectors: Putting Preclinical Findings into PerspectiveHuman Gene Therapy, 2004
- Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airwayNature Immunology, 2004
- Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2004
- Neutrophil elastase up‐regulates interleukin‐8 via toll‐like receptor 4FEBS Letters, 2003
- Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cellsviaIKK-β kinase pathwayEuropean Respiratory Journal, 2003
- Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase InhibitorJournal of Pharmacology and Experimental Therapeutics, 2003
- A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalitiesThe Journal of Pediatrics, 2001
- Exhaled nitric oxide is reduced in infants with cystic fibrosisThorax, 2001
- In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epitheliumJCI Insight, 2000
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995